Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

27.54
-1.3700-4.74%
Pre-market: 27.550.0100+0.04%07:20 EDT
Volume:1.42M
Turnover:39.20M
Market Cap:2.43B
PE:-6.29
High:29.09
Open:28.98
Low:27.33
Close:28.91
52wk High:47.65
52wk Low:22.30
Shares:88.16M
Float Shares:66.03M
Volume Ratio:0.94
T/O Rate:2.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3763
EPS(LYR):-2.2900
ROE:-80.88%
ROA:-46.18%
PB:4.41
PE(LYR):-12.03

Loading ...

Jul 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 23, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2025

Major Issues Report

Form 8-K - Current report
Apr 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 12, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Feb 04, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities